References

1. G Minotti,S Recalcati,P Menna,E Salvatorelli,G Corna,G Cairo (2004). Doxorubicin cardiotoxicity and the control of iron metabolism: Quinone-dependent and independent mechanisms.
2. B Kalyanaraman,Joy Joseph,Shashi Kalivendi,Suwei Wang,Eugene Konorev,Srigiridhar Kotamraju (2002). Doxorubicin-induced apoptosis: Implications in cardiotoxicity.
3. M Yoshida,I Shiojima,H Ikeda,I Komuro (2009). Chronic doxorubicin cardiotoxicity is mediated by oxidative dna damage-atm-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of rac1 activity.
4. D Lebrecht,A Geist,U Ketelsen,J Haberstroh,B Setzer,U Walker (2007). Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats.
5. Ashley Smuder,Andreas Kavazis,Kisuk Min,Scott Powers (1985). Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals.
6. B Sishi,B Loos,J Van Rooyen,A Engelbrecht (2013). Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity.
7. A Ascensão,P Oliveira,J Magalhães (2012). Exercise as a beneficial adjunct therapy during doxorubicin treatment-role of mitochondria in cardioprotection.
8. S Powers,D Criswell,J Lawler,D Martin,F Lieu,L Ji,R Herb (1993). Rigorous exercise training increases superoxide dismutase activity in ventricular myocardium.
9. Brock Jensen,Chia-Ying Lien,David Hydock,Carole Schneider,Reid Hayward (2013). Exercise Mitigates Cardiac Doxorubicin Accumulation and Preserves Function in the Rat.
10. D Hydock,C Lien,C Schneider,R Hayward (2008). Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction.
11. D Hydock,C Lien,B Jensen,C Schneider,R Hayward (2007). Exercise preconditioning provides long-adenocarcinoma cell lines.
12. Andrew Slot,Steven Molinski,Susan Cole (2011). Mammalian multidrug-resistance proteins (MRPs).
13. Elizabeth Hopper-Borge,Zhe-Sheng Chen,Irina Shchaveleva,Martin Belinsky,Gary Kruh (2004). Analysis of the Drug Resistance Profile of Multidrug Resistance Protein 7 (ABCC10).
14. Paiboon Jungsuwadee,Ramaneeya Nithipongvanitch,Yumin Chen,Terry Oberley,D Butterfield,Daret St. Clair,Mary Vore (2009). Mrp1 Localization and Function in Cardiac Mitochondria after Doxorubicin.
15. Traci Parry,Reid Hayward (2015). Exercise training does not affect anthracycline antitumor efficacy while attenuating cardiac dysfunction.
16. K Wonders,D Hydock,S Greufe,C Schneider,R Hayward (2009). Endurance exercise training preserves cardiac function in rats receiving doxorubicin and the her-2 inhibitor gw2974.
17. Inês Marques-Aleixo,Estela Santos-Alves,Diogo Mariani,David Rizo-Roca,Ana Padrão,Sílvia Rocha-Rodrigues,Ginés Viscor,J Torrella,Rita Ferreira,Paulo Oliveira,José Magalhães,António Ascensão (2014). Physical exercise prior and during treatment reduces sub-chronic doxorubicin-induced mitochondrial toxicity and oxidative stress.
18. Marion Bradford (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
19. Filipa Carvalho,Ana Burgeiro,Rita Garcia,António Moreno,Rui Carvalho,Paulo Oliveira (2014). Doxorubicin‐Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy.
20. J Doroshow,C Tallent,J Schechter (1985). Ultrastructural features of adriamycin-induced skeletal and cardiac muscle toxicity.
21. A Chicco,C Schneider,R Hayward (2006). Exercise training attenuates acute doxorubicin-induced cardiac dysfunction.
22. Andreas Kavazis,Ashley Smuder,Scott Powers (2014). Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle.
23. Abd El-Gawad,H El-Sawalhi,M (2004). Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: Role of aminoguanidine.
24. J Kwok,D Richardson (2003). Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: Inhibition of the ferritin iron mobilization pathway.
25. Chengsong Xie,Mark Lovell,William Markesbery (1998). Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity.
26. Piet Borst,Raymond Evers,Marcel Kool,Jan Wijnholds (1999). The multidrug resistance protein family.
27. Roger Deeley,Christopher Westlake,Susan Cole (2006). Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins.
28. Maurício Krause,Lino Oliveira,Elza Silveira,Damiana Vianna,Juliane Rossato,Bibiana Almeida,Mariana Rodrigues,Augustus Fernandes,João Costa,Rui Curi,Paulo De Bittencourt (2007). MRP1/GS‐X pump ATPase expression: is this the explanation for the cytoprotection of the heart against oxidative stress‐induced redox imbalance in comparison to skeletal muscle cells?.
29. Laura Gilliam,Kelsey Fisher-Wellman,Chien-Te Lin,Jill Maples,Brook Cathey,P Neufer (2013). The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle.
30. Kenichi Nunoya,Caroline Grant,Dawei Zhang,Susan Cole,Roger Deeley (2003). MOLECULAR CLONING AND PHARMACOLOGICAL CHARACTERIZATION OF RAT MULTIDRUG RESISTANCE PROTEIN 1 (MRP1).
31. S Dallas,D Miller,R Bendayan (2006). Multidrug resistance-associated proteins: Expression and function in the central nervous system.
32. C Grant,G Valdimarsson,D Hipfner,K Almquist,S Cole,R Deeley (1994). Overexpression of multidrug resistance-associated protein (mrp) increases resistance to natural product drugs.
33. J Hirrlinger,J Koènig,D Keppler,J Lindenau,J Schulz,R Dringen (2001). The multidrug resistance protein mrp1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress.